Status:
COMPLETED
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)
Lead Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsors:
University of Alabama at Birmingham
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
19+ years
Brief Summary
Rheumatoid arthritis (RA) is a long-term autoimmune disease that is characterized by pain, stiffness, inflammation, swelling, and sometimes destruction of joints. RA usually requires lifelong treatmen...
Detailed Description
RA is a chronic condition that causes inflammation of the joints and surrounding tissues. Symptoms may include pain, stiffness, swelling, and sometimes destruction of joints. RA can affect any joint, ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Group 1 Participants:
- Rheumatoid arthritis
- Self-declared as African American
- Exclusion Criteria for Group 1 Participants:
- Lupus
Exclusion
Key Trial Info
Start Date :
September 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
1613 Patients enrolled
Trial Details
Trial ID
NCT00815425
Start Date
September 1 2000
End Date
March 1 2012
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294